Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Qlife Holding AB's Enterprise Value is kr63.14 Mil.
Qlife Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-19.69 Mil. Therefore, Qlife Holding AB's EV-to-EBIT ratio for today is -3.21.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Qlife Holding AB's Enterprise Value is kr63.14 Mil.
Qlife Holding AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-18.41 Mil. Therefore, Qlife Holding AB's EV-to-EBITDA ratio for today is -3.43.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Qlife Holding AB's Enterprise Value is kr63.14 Mil.
Qlife Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.24 Mil. Therefore, Qlife Holding AB's EV-to-Revenue ratio for today is 264.18.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Qlife Holding AB's Enterprise Value is kr63.14 Mil.
Qlife Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-12.74 Mil. Therefore, Qlife Holding AB's EV-to-FCF ratio for today is -4.96.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Qlife Holding AB (OSTO:QLIFE) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Qlife Holding AB's current Enterprise Value is kr63.14 Mil.
Qlife Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-19.69 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Qlife Holding AB's current Enterprise Value is kr63.14 Mil.
Qlife Holding AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-18.41 Mil.
Qlife Holding AB's current Enterprise Value is kr63.14 Mil.
Qlife Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.24 Mil.
Qlife Holding AB's current Enterprise Value is kr63.14 Mil.
Qlife Holding AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-12.74 Mil.
Qlife Holding AB's current Enterprise Value is kr63.14 Mil.
Qlife Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-12.74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qlife Holding AB Enterprise Value Related Terms
Qlife Holding AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for Qlife Holding AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:QLIFE vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Qlife Holding AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qlife Holding AB Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Qlife Holding AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Qlife Holding AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qlife Holding AB (OSTO:QLIFE) has a Enterprise Value of kr63.14 Mil as of Jul. 04, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Qlife Holding AB and its competitors.
Is Qlife Holding AB's Enterprise Value too high?
Qlife Holding AB's current Enterprise Value is kr63.14 Mil. Overall, Qlife Holding AB has a GF Score™ of 15/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's Enterprise Value compare to ABT and SYK?
Qlife Holding AB's Enterprise Value of kr63.14 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Qlife Holding AB and its competitors. Qlife Holding AB's current Enterprise Value is kr63.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.76, compared to a current price of kr1.93 — trading 153.9% above its estimated fair value. The current Enterprise Value is kr63.14 Mil. Qlife Holding AB's overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current Enterprise Value is kr63.14 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued.
The current stock price of kr1.93 is trading 153.9% above its estimated GF Value™ of kr0.76.
GuruFocus considers Qlife Holding AB to be Significantly Overvalued.
Key valuation signals for OSTO:QLIFE:
Enterprise Value: kr63.14 Mil
GF Value™: kr0.76 vs. price of kr1.93 (153.9% above fair value)
No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
15GF Score
Get the complete analysis for OSTO:QLIFE
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLIFE has been successfully added to your 
